Some companies, including Lilly, are also exploring oral GLP-1 receptor agonists, which DIMarchi refers to as small molecule mimetrics. These molecules, however, are far more complex than traditional oral small molecules
small sample size, blood sampling on non-specific day of the menstrual cycle, very short duration of the treatment), might give rise to misleading results
These threads often weave together personal anecdotes, links to published studies, and crowd-sourced advice on where certain formulations fit within the larger wellness conversation
If you also take insulin, dont inject both medications into the exact same spot
BPC-157s demonstrated ability to heal intestinal mucosal damage and protect against various forms of GI insult provides targeted support during this challenging phase
None of these adds new pathway coverage - they just stack side effects